UMediC Group Berhad Income Statement

Financials in millions MYR. Fiscal year is August - July.

Millions MYR. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Revenue	51.5	48.56	54.57	45.43	50.74	34.12
Revenue Growth (YoY)	0.58%	-11.00%	20.11%	-10.46%	48.72%	44.09%
Cost of Revenue	27.68	26.2	31.9	26.5	32.08	21.55
Gross Profit	23.82	22.36	22.67	18.93	18.66	12.56
Selling, General & Admin	14.03	12.69	11.43	7.64	10.03	5.88
Operating Expenses	14.24	12.9	11.46	7.63	10.01	5.89
Operating Income	9.59	9.47	11.22	11.3	8.65	6.68
Interest Expense	-0.11	-0.07	-0.14	-0.25	-0.81	-0.73
Interest & Investment Income	-	-	-	-	0.12	0.04
Other Non Operating Income (Expenses)	1.42	1.45	1.56	1.88	0.53	0.55
EBT Excluding Unusual Items	10.9	10.85	12.64	12.93	8.48	6.54
Other Unusual Items	-	-	-	-	-	0.01
Pretax Income	10.9	10.85	12.64	12.93	8.48	6.55
Income Tax Expense	2.15	2.59	3.34	2.57	2.06	1.47
Earnings From Continuing Operations	8.75	8.26	9.3	10.36	6.43	5.09
Minority Interest in Earnings	-0.57	-0.13	-0.31	-0.05	-	-
Net Income	8.18	8.13	8.99	10.32	6.43	5.09
Net Income to Common	8.18	8.13	8.99	10.32	6.43	5.09
Net Income Growth	-2.15%	-9.53%	-12.84%	60.52%	26.33%	110.32%
Shares Outstanding (Basic)	374	374	374	374	234	374
Shares Outstanding (Diluted)	374	374	374	374	234	374
Shares Change (YoY)	-	-	-	59.51%	-37.31%	-
EPS (Basic)	0.02	0.02	0.02	0.03	0.03	0.01
EPS (Diluted)	0.02	0.02	0.02	0.03	0.03	0.01
EPS Growth	-2.21%	-9.54%	-12.84%	0.64%	101.51%	110.33%
Free Cash Flow	-5.73	3.14	-2.18	-3.51	7.47	-5.7
Free Cash Flow Per Share	-0.01	0.01	-0.01	-0.01	0.03	-0.01
Dividend Per Share	0.003	-	-	-	-	-
Gross Margin	46.26%	46.05%	41.55%	41.67%	36.78%	36.82%
Operating Margin	18.61%	19.49%	20.55%	24.88%	17.04%	19.57%
Profit Margin	15.88%	16.75%	16.48%	22.71%	12.67%	14.91%
Free Cash Flow Margin	-11.13%	6.47%	-4.00%	-7.72%	14.72%	-16.71%
EBITDA	12.8	12.31	13.58	13.35	10.18	7.2
EBITDA Margin	24.86%	25.35%	24.89%	29.38%	20.06%	21.12%
D&A For EBITDA	3.22	2.84	2.37	2.05	1.53	0.53
EBIT	9.59	9.47	11.22	11.3	8.65	6.68
EBIT Margin	18.61%	19.49%	20.55%	24.88%	17.04%	19.57%
Effective Tax Rate	19.72%	23.84%	26.45%	19.86%	24.24%	22.38%

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.